| 3001 | EBAG9/TGFB1 ratio | GCST90314570 | 4.11 |
| 3002 | Haemorrhoids | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | UKBB00000294 | 4.11 |
| 3003 | PI3 levels | GCST90470230 | 4.10 |
| 3004 | Total Alkenylphosphatidylcholine levels | GCST90025835 | 4.10 |
| 3005 | Disorders of plasma protein metabolism (PheCode 270.3) | GCST90475709 | 4.10 |
| 3006 | SCARA5/SCARF2 ratio | GCST90315808 | 4.10 |
| 3007 | Coronary atherosclerosis | FING00000359 | 4.10 |
| 3008 | Sexual abuse | GCST90551837 | 4.10 |
| 3009 | MTIF3 levels | GCST90469957 | 4.10 |
| 3010 | Metabolonic lactone sulfate levels | GCST90200257 | 4.10 |
| 3011 | Angina pectoris | GCST90018573 | 4.10 |
| 3012 | CRADD/MAP4K5 ratio | GCST90314240 | 4.10 |
| 3013 | SPP1 levels | GCST90470733 | 4.09 |
| 3014 | IDP dMRI TBSS MD Posterior thalamic radiation R | GCST90004055 | 4.09 |
| 3015 | aparc-DKTatlas rh volume parahippocampal | GCST90002907 | 4.09 |
| 3016 | NFX1 levels | GCST90470041 | 4.09 |
| 3017 | IDP dMRI TBSS MO Superior corona radiata L | GCST90003977 | 4.09 |
| 3018 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91 | ECGU000091 | 4.08 |
| 3019 | Free cholesterol in LDL (UKB data field 23421) | GCST90269518 | 4.08 |
| 3020 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T249 | ECGU000249 | 4.08 |
| 3021 | C21orf58 levels | GCST90618380 | 4.08 |
| 3022 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T335 | ECGU000335 | 4.07 |
| 3023 | Phospholipids to Total Lipids in Small HDL percentage | GCST90499505 | 4.07 |
| 3024 | Disorders of iris and ciliary body (PheCode 379.5) | GCST90475899 | 4.07 |
| 3025 | Cholesterol to Total Lipids in Small VLDL percentage | GCST90499764 | 4.07 |
| 3026 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19 | ECGA000019 | 4.07 |
| 3027 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T111 | ECGA000111 | 4.07 |
| 3028 | PEBP1 levels | GCST90470205 | 4.07 |
| 3029 | 1-arachidonoylglycerophosphoinositol levels | GCST90243754 | 4.07 |
| 3030 | PTPRF/PTPRS ratio | GCST90315751 | 4.07 |
| 3031 | ATF6 levels | GCST90240816 | 4.07 |
| 3032 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T164 | ECGA000164 | 4.07 |
| 3033 | CSF1/IL10RB ratio | GCST90314284 | 4.06 |
| 3034 | Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels | GCST90060295 | 4.06 |
| 3035 | PTPN6 levels | GCST90470377 | 4.06 |
| 3036 | Phenylalanine levels | GCST90243407 | 4.06 |
| 3037 | ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cyst | GCST90454215 | 4.05 |
| 3038 | Drive faster than motorway speed limit | Physical activity | UKBB00000194 | 4.05 |
| 3039 | Sphinganine-1-phosphate levels | GCST90199845 | 4.05 |
| 3040 | T1 FreeSurfer DKT rh insula area | GCST90384317 | 4.05 |
| 3041 | HippSubfield lh volume subiculum-head | GCST90002671 | 4.05 |
| 3042 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502415 | 4.05 |
| 3043 | SUMF2 levels | GCST90470784 | 4.04 |
| 3044 | Age started wearing glasses (UKB data field 2217) | GCST90468156 | 4.03 |
| 3045 | Low hand grip strength (60 years and older) (FNIH) | GCST90007529 | 4.03 |
| 3046 | DTI TBSS L3 Cingulum hippocampus L | GCST90384561 | 4.02 |
| 3047 | rfMRI amplitudes (ICA100 node 15) | GCST90004603 | 4.02 |
| 3048 | GADD45GIP1 levels | GCST90469293 | 4.02 |
| 3049 | ERBB3/IL1R2 ratio | GCST90314689 | 4.02 |
| 3050 | Telomere length (principal component 2) | GCST90435145 | 4.01 |
| 3051 | GAL levels | GCST90469300 | 4.01 |
| 3052 | F11 levels | GCST90469165 | 4.01 |
| 3053 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T396 | ECGU000396 | 4.01 |
| 3054 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T408 | ECGU000408 | 4.01 |
| 3055 | X-12844 levels | GCST90200523 | 4.01 |
| 3056 | Peripheral artery disease | GCST90018670 | 4.01 |
| 3057 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T283 | ECGA000283 | 4.00 |
| 3058 | HMBS/PKLR ratio | GCST90315063 | 4.00 |
| 3059 | IGFBP3 levels | GCST90469529 | 4.00 |
| 3060 | CD83/LAMP3 ratio | GCST90313906 | 4.00 |
| 3061 | Lymphoid neoplasms (P-cell phenocluster) | GCST90624737 | 4.00 |
| 3062 | IDP dMRI ProbtrackX L3 ar l | GCST90004300 | 4.00 |
| 3063 | ACYP1 levels | GCST90468214 | 3.99 |
| 3064 | FLT3 levels | GCST90469251 | 3.99 |
| 3065 | Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000429 | 3.99 |
| 3066 | SCG3 levels | GCST90470539 | 3.98 |
| 3067 | aseg global volume BrainSegNotVent | GCST90002591 | 3.98 |
| 3068 | CD83 levels | GCST90468652 | 3.98 |
| 3069 | MNDA levels | GCST90469927 | 3.98 |
| 3070 | SERPINB1/SERPINB9 ratio | GCST90315827 | 3.98 |
| 3071 | BA-exvivo rh volume BA1 | GCST90002849 | 3.98 |
| 3072 | FGFBP1 levels | GCST90469230 | 3.98 |
| 3073 | QDPR levels | GCST90470400 | 3.97 |
| 3074 | Linoleic acid levels | GCST90502294 | 3.97 |
| 3075 | CPM levels | GCST90468843 | 3.97 |
| 3076 | VWF levels | GCST90471065 | 3.96 |
| 3077 | Disorders of iron metabolism (PheCode 275.1) | GCST90475743 | 3.96 |
| 3078 | SMPD1 levels | GCST90470684 | 3.96 |
| 3079 | FKBPL levels | GCST90469246 | 3.95 |
| 3080 | Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels | GCST90060261 | 3.95 |
| 3081 | PARP1 levels | GCST90470160 | 3.95 |
| 3082 | Triacylglycerol_53:3_[M+NH4]1+ levels | GCST90060528 | 3.94 |
| 3083 | Concentration of small LDL particles | GCST90499660 | 3.94 |
| 3084 | Phospholipid levels in VLDL | GCST90093001 | 3.94 |
| 3085 | LDL cholesterol levels | GCST90498353 | 3.94 |
| 3086 | Cholesteryl ester levels in large VLDL | GCST90092870 | 3.93 |
| 3087 | Alpha-hydroxyisovalerate levels | GCST90199736 | 3.93 |
| 3088 | PDGFRA levels | GCST90421093 | 3.93 |
| 3089 | C1R levels | GCST90468493 | 3.93 |
| 3090 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185 | ECGU000185 | 3.92 |
| 3091 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391 | ECGU000391 | 3.92 |
| 3092 | N-acetyl-1-methylhistidine levels | GCST90200690 | 3.92 |
| 3093 | aparc-Desikan rh thickness transversetemporal | GCST90003511 | 3.92 |
| 3094 | CD69/F2R ratio | GCST90313877 | 3.91 |
| 3095 | RPE levels | GCST90470495 | 3.91 |
| 3096 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T165 | ECGA000165 | 3.91 |
| 3097 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T409 | ECGU000409 | 3.91 |
| 3098 | EPHB6/TNFRSF9 ratio | GCST90314682 | 3.90 |
| 3099 | Total fatty acid levels | GCST90502710 | 3.90 |
| 3100 | CD69/CHMP1A ratio | GCST90313868 | 3.89 |
| 3101 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 3.89 |
| 3102 | Spread type: Butter vs never use spread (UKB data field 1428) | GCST90132952 | 3.89 |
| 3103 | ESAM/LAMA4 ratio | GCST90314713 | 3.89 |
| 3104 | aseg global volume CC-Anterior | GCST90002611 | 3.89 |
| 3105 | BA-exvivo lh volume BA1 | GCST90002835 | 3.89 |
| 3106 | PTH levels | GCST90470372 | 3.89 |
| 3107 | aseg lh number HolesBeforeFixing | GCST90002630 | 3.88 |
| 3108 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T88 | ECGU000088 | 3.88 |
| 3109 | total cholesterol (mean, inv-norm transformed) | GCST90476424 | 3.88 |
| 3110 | HSPB1 levels | GCST90469489 | 3.88 |
| 3111 | NFASC levels | GCST90470031 | 3.88 |
| 3112 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498919 | 3.87 |
| 3113 | Ambidextrousness | GCST90013420 | 3.87 |
| 3114 | SDK2 levels | GCST90470562 | 3.87 |
| 3115 | SDC4/SMAD1 ratio | GCST90315820 | 3.87 |
| 3116 | Hydrocele | FING00000627 | 3.86 |
| 3117 | Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)? | GCST90475210 | 3.86 |
| 3118 | GRAP2/TYMP ratio | GCST90314990 | 3.85 |
| 3119 | Descending aorta diameter | GCST90267391 | 3.85 |
| 3120 | DTI autoptx L2 ptr l tract | GCST90385185 | 3.85 |
| 3121 | End stage renal disease (PheCode 585.32) | GCST90476126 | 3.85 |
| 3122 | aparc-pial rh area TotalSurface | GCST90003174 | 3.85 |
| 3123 | TNFSF10 levels | GCST90012011 | 3.85 |
| 3124 | CCBL2 levels | GCST90241722 | 3.85 |
| 3125 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T172 | ECGA000172 | 3.84 |
| 3126 | SMAD2 levels | GCST90470676 | 3.84 |
| 3127 | CST1 levels | GCST90468893 | 3.84 |
| 3128 | Urine X-24798 levels in chronic kidney disease | GCST90266802 | 3.83 |
| 3129 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T139 | ECGA000139 | 3.83 |
| 3130 | VPS53 levels | GCST90471048 | 3.83 |
| 3131 | MGLL/PTPN6 ratio | GCST90315440 | 3.82 |
| 3132 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 3.82 |
| 3133 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T184 | ECGU000184 | 3.82 |
| 3134 | BACH1/HEXIM1 ratio | GCST90313440 | 3.82 |
| 3135 | INSR levels | GCST90469623 | 3.82 |
| 3136 | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | GCST90004345 | 3.81 |
| 3137 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183 | ECGU000183 | 3.81 |
| 3138 | PTRHD1 levels | GCST90470389 | 3.81 |
| 3139 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T338 | ECGU000338 | 3.81 |
| 3140 | PTPRS levels | GCST90470387 | 3.81 |
| 3141 | CX3CL1 levels | GCST90012074 | 3.80 |
| 3142 | Milk type used: Soy milk vs never have milk (UKB data field 1418) | GCST90132943 | 3.80 |
| 3143 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499832 | 3.80 |
| 3144 | C2/SSC5D ratio | GCST90313555 | 3.80 |
| 3145 | APOD levels | GCST90468337 | 3.80 |
| 3146 | IDP dMRI ProbtrackX ICVF fma | GCST90004385 | 3.80 |
| 3147 | PDGFA/VEGFC ratio | GCST90315622 | 3.80 |
| 3148 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78 | ECGA000078 | 3.80 |
| 3149 | T1 FreeSurfer BA rh BA3b exvivo area | GCST90385550 | 3.80 |
| 3150 | ULBP2 levels | GCST90471008 | 3.80 |
| 3151 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390 | ECGA000390 | 3.80 |
| 3152 | aparc-a2009s rh area G-precentral | GCST90003399 | 3.79 |
| 3153 | CPXM1/DKK1 ratio | GCST90314218 | 3.79 |
| 3154 | PPCDC levels | GCST90470290 | 3.79 |
| 3155 | DPP4 levels | GCST90469033 | 3.79 |
| 3156 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T163 | ECGA000163 | 3.78 |
| 3157 | PAK4 levels | GCST90470150 | 3.78 |
| 3158 | Left-hemisphere somatomotor network to left-hemisphere somatomotor network white-matter structural connectivity | GCST90302669 | 3.78 |
| 3159 | PLIN3/VSIR ratio | GCST90315679 | 3.78 |
| 3160 | Reticulocyte count | GCST004622 | 3.78 |
| 3161 | Gout (PheCode 274.1) | GCST90043662 | 3.78 |
| 3162 | CD99/CD99L2 ratio | GCST90313923 | 3.77 |
| 3163 | DTI autoptx FA atr r tract | GCST90385115 | 3.77 |
| 3164 | aparc-a2009s lh volume G-front-inf-Opercular | GCST90002936 | 3.77 |
| 3165 | DHEAS levels | GCST90199673 | 3.77 |
| 3166 | Hearing (confirmatory factor analysis Factor 32) | GCST90309366 | 3.76 |
| 3167 | IDP dMRI ProbtrackX FA atr l | GCST90003927 | 3.75 |
| 3168 | Phenylacetylglutamate levels | GCST90200069 | 3.75 |
| 3169 | GBP4 levels | GCST90469313 | 3.75 |
| 3170 | Triacylglycerol_45:4_[M+NH4]1+ levels | GCST90060333 | 3.75 |
| 3171 | Total Sphingomyelin levels | GCST90025842 | 3.75 |
| 3172 | MITD1/WWP2 ratio | GCST90315458 | 3.75 |
| 3173 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T341 | ECGA000341 | 3.75 |
| 3174 | QSOX1 levels | GCST90470402 | 3.75 |
| 3175 | aparc-a2009s lh area S-calcarine | GCST90003340 | 3.74 |
| 3176 | IDP dMRI TBSS OD Superior corona radiata R | GCST90004426 | 3.74 |
| 3177 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T337 | ECGU000337 | 3.74 |
| 3178 | PKD1 levels | GCST90470240 | 3.74 |
| 3179 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T284 | ECGA000284 | 3.74 |
| 3180 | CSNK2A1 levels | GCST90468889 | 3.74 |
| 3181 | IDP dMRI TBSS L1 Fornix | GCST90004080 | 3.74 |
| 3182 | SRC levels | GCST90470741 | 3.74 |
| 3183 | Left-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302682 | 3.74 |
| 3184 | IDP T1 FAST ROIs R mid front gyrus | GCST90002458 | 3.74 |
| 3185 | aparc-DKTatlas lh area lateraloccipital | GCST90003243 | 3.74 |
| 3186 | TNN levels | GCST90470927 | 3.73 |
| 3187 | APOB levels | UKBB00000041 | 3.73 |
| 3188 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498956 | 3.73 |
| 3189 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178 | ECGU000178 | 3.73 |
| 3190 | Triacylglycerol_54:5_[M+NH4]1+ levels | GCST90060539 | 3.73 |
| 3191 | Principal component-derived dietary pattern 40 | GCST90133045 | 3.72 |
| 3192 | QC SWI-to-T1 linear alignment discrepancy | GCST90006352 | 3.72 |
| 3193 | SERPINA12 levels | GCST90470581 | 3.72 |
| 3194 | MSRA levels | GCST90469951 | 3.72 |
| 3195 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499700 | 3.72 |
| 3196 | EPCAM levels | GCST90469126 | 3.71 |
| 3197 | Concentration of IDL particles (UKB data field 23523) | GCST90269620 | 3.71 |
| 3198 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499069 | 3.71 |
| 3199 | C-reactive protein levels (CRP.4337.49.2) | GCST90240503 | 3.70 |
| 3200 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 3.69 |
| 3201 | AIFM1/SIRT2 ratio | GCST90313221 | 3.69 |
| 3202 | Vanillactate levels | GCST90199978 | 3.69 |
| 3203 | CA5A/GRPEL1 ratio | GCST90313590 | 3.69 |
| 3204 | Sphingomyelin levels | GCST90092982 | 3.68 |
| 3205 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T395 | ECGU000395 | 3.68 |
| 3206 | ITGB5 levels | GCST90469645 | 3.68 |
| 3207 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T389 | ECGU000389 | 3.68 |
| 3208 | DIABLO/PRKAR1A ratio | GCST90314469 | 3.68 |
| 3209 | CNTN3/FETUB ratio | GCST90314164 | 3.68 |
| 3210 | Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302695 | 3.68 |
| 3211 | Androstenediol (3beta,17beta) disulfate (1) levels | GCST90199842 | 3.68 |
| 3212 | IDP dMRI ProbtrackX ICVF str l | GCST90004398 | 3.68 |
| 3213 | Non-cancer illness code, self-reported - osteoarthritis | Medical conditions | UKBB00000521 | 3.67 |
| 3214 | DTI autoptx L3 ilf r tract | GCST90385208 | 3.67 |
| 3215 | DTI autoptx L2 slf l tract | GCST90385187 | 3.66 |
| 3216 | Radial peak diastolic strain rate | GCST90019014 | 3.66 |
| 3217 | NOS3 levels | GCST90470064 | 3.66 |
| 3218 | IDP dMRI ProbtrackX ICVF ml r | GCST90004393 | 3.66 |
| 3219 | Pain type(s) experienced in last month - Pain all over the body | Pain | UKBB00000632 | 3.66 |
| 3220 | CCN5/IGFBP6 ratio | GCST90313723 | 3.65 |
| 3221 | NECTIN4 levels | GCST90470021 | 3.65 |
| 3222 | Emphysema (PheCode 496.1) | GCST90476028 | 3.65 |
| 3223 | Left ventricular end diastole anterolateral wall thickness | GCST90278517 | 3.65 |
| 3224 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110 | ECGU000110 | 3.65 |
| 3225 | Left molecular layer hippocampal volume (body) | GCST90267953 | 3.65 |
| 3226 | CD58/LTBR ratio | GCST90313851 | 3.64 |
| 3227 | LPO levels | GCST90241730 | 3.64 |
| 3228 | DTI TBSS MD Sagittal stratum R | GCST90384602 | 3.64 |
| 3229 | ADGRD1 levels | GCST90468235 | 3.64 |
| 3230 | Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) | GCST90476220 | 3.64 |
| 3231 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 3.64 |
| 3232 | TNFAIP8L2 levels | GCST90470897 | 3.64 |
| 3233 | TNFRSF11B/TNFSF11 ratio | GCST90315930 | 3.64 |
| 3234 | Microscopic polyangiitis | FING00000817 | 3.64 |
| 3235 | SNX9/STIP1 ratio | GCST90315864 | 3.64 |
| 3236 | GGT5 levels | GCST90469337 | 3.64 |
| 3237 | Major depressive disorder (ICD-10 coded) | GCST005903 | 3.63 |
| 3238 | ACE2/GGT1 ratio | GCST90313153 | 3.63 |
| 3239 | Deep venous thrombosis | GCST90468122 | 3.63 |
| 3240 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 3.62 |
| 3241 | IDP dMRI ProbtrackX L3 unc r | GCST90004326 | 3.62 |
| 3242 | PDCD1LG2 levels | GCST90470180 | 3.62 |
| 3243 | ESAM/SORT1 ratio | GCST90314716 | 3.62 |
| 3244 | CA4/FOLR2 ratio | GCST90313585 | 3.62 |
| 3245 | Left ventricular wall thickness (maximal) | GCST90435263 | 3.61 |
| 3246 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186 | ECGU000186 | 3.61 |
| 3247 | Total lipid levels in VLDL | GCST90092999 | 3.61 |
| 3248 | aparc-DKTatlas lh volume caudalmiddlefrontal | GCST90002864 | 3.61 |
| 3249 | Concentration of VLDL particles | GCST90093000 | 3.61 |
| 3250 | CD244/CD84 ratio | GCST90313762 | 3.61 |
| 3251 | N6-methyllysine levels in chronic kidney disease | GCST90257530 | 3.60 |
| 3252 | IGFBPL1 levels | GCST90179323 | 3.60 |
| 3253 | Concentration of small LDL particles | GCST90499669 | 3.60 |
| 3254 | Phospholipids in VLDL | GCST90500266 | 3.60 |
| 3255 | Volume of right paralaminar nucleus | GCST90474928 | 3.60 |
| 3256 | Oranges liking | GCST90094807 | 3.60 |
| 3257 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T354 | ECGA000354 | 3.60 |
| 3258 | OPLAH levels | GCST90470127 | 3.60 |
| 3259 | IDP dMRI ProbtrackX ICVF atr l | GCST90004377 | 3.60 |
| 3260 | Venous thromboembolism | GCST90399744 | 3.59 |
| 3261 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418 | ECGU000418 | 3.58 |
| 3262 | Age when finished full-time education (weighted GWA) | GCST90267281 | 3.58 |
| 3263 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 3.58 |
| 3264 | Globe artichoke liking | GCST90094771 | 3.58 |
| 3265 | HMBS/PSMG3 ratio | GCST90315064 | 3.58 |
| 3266 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T254 | ECGA000254 | 3.58 |
| 3267 | APOA2 levels | GCST90468332 | 3.58 |
| 3268 | SELP levels | GCST90470569 | 3.58 |
| 3269 | CC2D1A levels | GCST90468557 | 3.58 |
| 3270 | SIAE/SNAP29 ratio | GCST90315843 | 3.57 |
| 3271 | IDP dMRI TBSS L2 Uncinate fasciculus R | GCST90004167 | 3.57 |
| 3272 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502181 | 3.57 |
| 3273 | Neutrophil count | GCST90025977 | 3.57 |
| 3274 | EIF4B levels | GCST90469094 | 3.57 |
| 3275 | Eustachian tube disorders (PheCode 381.2) | GCST90475904 | 3.56 |
| 3276 | TNFRSF4/TNFRSF9 ratio | GCST90315939 | 3.56 |
| 3277 | THTPA levels | GCST90470860 | 3.56 |
| 3278 | Bicuspidal aortic valve syndrome | FING00000212 | 3.56 |
| 3279 | Pain type(s) experienced in last month - Knee pain | Pain | UKBB00000629 | 3.55 |
| 3280 | LCP1 levels | GCST90469748 | 3.55 |
| 3281 | NSFL1C levels | GCST90470089 | 3.55 |
| 3282 | SLITRK1 levels | GCST90470669 | 3.55 |
| 3283 | Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systems | UKBB00000625 | 3.55 |
| 3284 | Arthropathies | FING00000107 | 3.54 |
| 3285 | MELTF levels | GCST90469885 | 3.54 |
| 3286 | 1-stearoyl-2-oleoyl-GPS (18:0/18:1) levels | GCST90199652 | 3.54 |
| 3287 | Disorders of lacrimal system | FING00000441 | 3.54 |
| 3288 | DEFA1_DEFA1B/PTGDS ratio | GCST90314455 | 3.54 |
| 3289 | AXIN1/HEXIM1 ratio | GCST90313408 | 3.53 |
| 3290 | Pregnenediol sulfate (C21H34O5S) levels | GCST90199861 | 3.53 |
| 3291 | AMBP/RARRES2 ratio | GCST90313256 | 3.53 |
| 3292 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182 | ECGU000182 | 3.53 |
| 3293 | GBP6 levels | GCST90241368 | 3.53 |
| 3294 | DLK1/FAP ratio | GCST90314491 | 3.53 |
| 3295 | TCTN3 levels | GCST90470823 | 3.52 |
| 3296 | F9/FETUB ratio | GCST90314746 | 3.52 |
| 3297 | Salad / raw vegetable intake | Diet | UKBB00000761 | 3.52 |
| 3298 | DSG2 levels | GCST90427825 | 3.52 |
| 3299 | Total lipid levels in lipoprotein particles | GCST90500086 | 3.52 |
| 3300 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus R | GCST90004367 | 3.52 |
| 3301 | Free Cholesterol to Total Lipids in Small HDL percentage | GCST90499436 | 3.52 |
| 3302 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | GCST90320903 | 3.51 |
| 3303 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T144 | ECGA000144 | 3.51 |
| 3304 | REST UKBBICA NODEamps25 0009 | GCST90385492 | 3.51 |
| 3305 | Triacylglycerol_54:3_[M+NH4]1+ levels | GCST90060541 | 3.51 |
| 3306 | Left ventricular end systole anterospetal wall thickness | GCST90278513 | 3.51 |
| 3307 | MANF/NCK2 ratio | GCST90315359 | 3.51 |
| 3308 | TGFB1 levels | GCST90470843 | 3.51 |
| 3309 | AHSP levels | GCST90468264 | 3.50 |
| 3310 | IDP dMRI TBSS OD Superior fronto-occipital fasciculus L | GCST90004445 | 3.50 |
| 3311 | Abnormality of gait (PheCode 350.2) | GCST90475841 | 3.50 |
| 3312 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502168 | 3.50 |
| 3313 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T340 | ECGU000340 | 3.50 |
| 3314 | Left ventricular end systole inferoseptal wall thickness | GCST90278508 | 3.50 |
| 3315 | THBS2 levels | GCST90470854 | 3.49 |
| 3316 | PDAP1 levels | GCST90470179 | 3.49 |
| 3317 | Pregnanediol-3-glucuronide levels | GCST90199917 | 3.49 |
| 3318 | IDP dMRI ProbtrackX OD str l | GCST90004473 | 3.49 |
| 3319 | PTPRF levels | GCST90470381 | 3.49 |
| 3320 | FURIN levels | GCST90469277 | 3.49 |
| 3321 | Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428) | GCST90132951 | 3.49 |
| 3322 | Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary Operations | UKBB00000579 | 3.48 |
| 3323 | PPIB levels | GCST90470291 | 3.48 |
| 3324 | NDUFB7 levels | GCST90470015 | 3.48 |
| 3325 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T125 | ECGU000125 | 3.48 |
| 3326 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T132 | ECGU000132 | 3.48 |
| 3327 | IL1B levels | GCST90469570 | 3.48 |
| 3328 | DTI autoptx L3 ptr l tract | GCST90385212 | 3.48 |
| 3329 | GSTA3 levels | GCST90469412 | 3.48 |
| 3330 | IDP dMRI TBSS ICVF Cingulum hippocampus R | GCST90004363 | 3.48 |
| 3331 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels | GCST90200060 | 3.48 |
| 3332 | NECTIN4/TGFBR2 ratio | GCST90315535 | 3.47 |
| 3333 | Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302820 | 3.47 |
| 3334 | SERPINA4 levels | GCST90470584 | 3.47 |
| 3335 | Free cholesterol levels in IDL | GCST90092835 | 3.47 |
| 3336 | Fruit intake (standard GWA) | GCST90267282 | 3.47 |
| 3337 | SERPINA3 levels | GCST90470583 | 3.46 |
| 3338 | Saturated fatty acids to total fatty acids percentage | GCST90502700 | 3.46 |
| 3339 | SUSD4 levels | GCST90470788 | 3.46 |
| 3340 | DKK1/SERPINE1 ratio | GCST90314480 | 3.46 |
| 3341 | VLDL cholesterol levels | GCST90092996 | 3.46 |
| 3342 | Free cholesterol in large LDL (UKB data field 23535) | GCST90269632 | 3.45 |
| 3343 | Right ventricular end diastolic volume (MTAG) | GCST90134592 | 3.45 |
| 3344 | Free cholesterol levels in medium VLDL | GCST90092920 | 3.45 |
| 3345 | Cholesterol to total lipids ratio in medium HDL | GCST90092893 | 3.45 |
| 3346 | Codeine or tramadol medication | FING00000311 | 3.45 |
| 3347 | PRTN3 levels | GCST90470348 | 3.45 |
| 3348 | Omega-6 fatty acid levels | GCST90502503 | 3.45 |
| 3349 | Autorefraction - 3mm asymmetry angle (left) | Eyesight | UKBB00000060 | 3.45 |
| 3350 | aparc-Desikan lh area fusiform | GCST90003079 | 3.45 |
| 3351 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T319 | ECGU000319 | 3.44 |
| 3352 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T67 | ECGU000067 | 3.44 |
| 3353 | 1-(1-enyl-palmitoyl)-GPC (p-16:0) levels | GCST90199899 | 3.44 |
| 3354 | IDP dMRI TBSS MD Uncinate fasciculus R | GCST90004071 | 3.44 |
| 3355 | Glycoprotein acetyls levels | GCST90497320 | 3.44 |
| 3356 | Nummular dermatitis | FING00000893 | 3.43 |
| 3357 | Cholesteryl Esters to Total Lipids in Medium LDL percentage | GCST90498747 | 3.43 |
| 3358 | Omega-6 fatty acid levels | GCST90502095 | 3.43 |
| 3359 | Polyunsaturated fatty acid levels | GCST90502142 | 3.43 |
| 3360 | LRRC25 levels | GCST90469801 | 3.42 |
| 3361 | IDP T1 FAST ROIs L caudate | GCST90002549 | 3.42 |
| 3362 | Trunk fat percentage | Impedance measures | UKBB00000864 | 3.42 |
| 3363 | SDC4 levels | GCST90470559 | 3.42 |
| 3364 | Concentration of medium VLDL particles | GCST90092923 | 3.41 |
| 3365 | red cell diameter width (RDW, mean, inv-norm transformed) | GCST90476361 | 3.41 |
| 3366 | Total cholesterol minus HDL-C levels | GCST90499130 | 3.41 |
| 3367 | CREG1 levels | GCST90468857 | 3.41 |
| 3368 | ITGA5/VCAM1 ratio | GCST90315206 | 3.41 |
| 3369 | CLEC4G levels | GCST90468774 | 3.41 |
| 3370 | HippSubfield rh volume Whole-hippocampal-body | GCST90002709 | 3.41 |
| 3371 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T31 | ECGA000031 | 3.41 |
| 3372 | High cholesterol | GCST90468134 | 3.41 |
| 3373 | KYAT1 levels | GCST90469721 | 3.41 |
| 3374 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 3.41 |
| 3375 | IDP dMRI ProbtrackX ICVF ilf l | GCST90004389 | 3.40 |
| 3376 | IDP dMRI TBSS FA Anterior corona radiata R | GCST90003899 | 3.40 |
| 3377 | Prescriptions - anti-malarial | UKBB00000663 | 3.40 |
| 3378 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 3.40 |
| 3379 | SCARF1 levels | GCST90470536 | 3.39 |
| 3380 | Other chondrocalcinosis | FING00000977 | 3.39 |
| 3381 | Reticulocyte fraction of red cells | GCST90002406 | 3.39 |
| 3382 | ALDH1A1 levels | GCST90468280 | 3.39 |
| 3383 | DTI autoptx MD str l tract | GCST90385243 | 3.39 |
| 3384 | Isoleucine levels (UKB data field 23465) | GCST90269562 | 3.39 |
| 3385 | Biological Grandparent (maternal): Alzheimer's / Other Dementia | GCST90475484 | 3.39 |
| 3386 | THBD levels | GCST90470853 | 3.39 |
| 3387 | Osteoarthritis | GCST90134279 | 3.38 |
| 3388 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360 | ECGA000360 | 3.38 |
| 3389 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T286 | ECGA000286 | 3.38 |
| 3390 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489 | ECGA000489 | 3.38 |
| 3391 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498926 | 3.37 |
| 3392 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187 | ECGU000187 | 3.37 |
| 3393 | Right-hemisphere limbic network to thalamus white-matter structural connectivity | GCST90302827 | 3.37 |
| 3394 | Total phospholipids in lipoprotein particles (UKB data field 23411) | GCST90269508 | 3.37 |
| 3395 | IL18BP levels | GCST90469564 | 3.37 |
| 3396 | PLIN3 levels | GCST90470259 | 3.37 |
| 3397 | ESAM/PDGFB ratio | GCST90314714 | 3.37 |
| 3398 | CD84/CDKN1A ratio | GCST90313909 | 3.36 |
| 3399 | IL7R levels | GCST90469605 | 3.36 |
| 3400 | SNAP29/TJAP1 ratio | GCST90315861 | 3.36 |
| 3401 | IDP dMRI ProbtrackX ICVF ifo l | GCST90004387 | 3.36 |
| 3402 | Number of correct matches in round | Pairs matching | UKBB00000532 | 3.36 |
| 3403 | Retinal arteriolar width | GCST90270398 | 3.36 |
| 3404 | F2R/ITGB1BP2 ratio | GCST90314731 | 3.36 |
| 3405 | Concentration of VLDL particles | GCST90500246 | 3.35 |
| 3406 | ABHD14B/CCS ratio | GCST90313139 | 3.35 |
| 3407 | Follicle stimulating hormone levels | GCST90483476 | 3.35 |
| 3408 | PDGFB/VEGFC ratio | GCST90315635 | 3.35 |
| 3409 | rfMRI amplitudes (ICA100 node 27) | GCST90004615 | 3.35 |
| 3410 | TRIM21 levels | GCST90470964 | 3.35 |
| 3411 | BCHE levels | GCST90468429 | 3.35 |
| 3412 | Body mass index (BMI) | Body size measures | UKBB00000103 | 3.35 |
| 3413 | Father's age at death | Family history | UKBB00000241 | 3.35 |
| 3414 | CRKL levels | GCST90468867 | 3.34 |
| 3415 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T112 | ECGU000112 | 3.34 |
| 3416 | Cholesteryl ester levels in VLDL | GCST90092997 | 3.33 |
| 3417 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320620 | 3.33 |
| 3418 | Lactate levels (UKB data field 23471) | GCST90269568 | 3.33 |
| 3419 | Personal history of certain other diseases | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000642 | 3.33 |
| 3420 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T347 | ECGA000347 | 3.33 |
| 3421 | Myocardial fractal dimension (slice 4) | GCST90000290 | 3.33 |
| 3422 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T337 | ECGA000337 | 3.33 |
| 3423 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46) | GCST90320609 | 3.33 |
| 3424 | IDP dMRI TBSS MD Anterior limb of internal capsule L | GCST90004044 | 3.32 |
| 3425 | PSRC1/SMAD1 ratio | GCST90315741 | 3.32 |
| 3426 | 1-stearoyl-gpc (18:0) levels | GCST90199732 | 3.32 |
| 3427 | Myocardial infarction, strict | FING00000852 | 3.32 |
| 3428 | BA-exvivo rh area BA1 | GCST90003221 | 3.32 |
| 3429 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128 | ECGU000128 | 3.32 |
| 3430 | CCDC80/CHRDL1 ratio | GCST90313670 | 3.31 |
| 3431 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle R | GCST90004337 | 3.31 |
| 3432 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391 | ECGA000391 | 3.31 |
| 3433 | JAM2/TGFBR2 ratio | GCST90315238 | 3.30 |
| 3434 | Reticulocyte fraction of red cells | GCST004619 | 3.30 |
| 3435 | SMPDL3A levels | GCST90470686 | 3.30 |
| 3436 | ST3GAL1 levels | GCST90470752 | 3.30 |
| 3437 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T359 | ECGU000359 | 3.30 |
| 3438 | AHSP/BLVRB ratio | GCST90313214 | 3.30 |
| 3439 | Total lipid levels in medium VLDL | GCST90092922 | 3.30 |
| 3440 | VASH1 levels | GCST90471026 | 3.29 |
| 3441 | ILKAP levels | GCST90469608 | 3.29 |
| 3442 | Mental and behavioural disorders due to use of other stimulants, including caffeine | FING00000811 | 3.29 |
| 3443 | IFNGR1 levels | GCST90469513 | 3.29 |
| 3444 | CXCL3 levels | GCST90468931 | 3.28 |
| 3445 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T252 | ECGU000252 | 3.28 |
| 3446 | HippSubfield lh volume Whole-hippocampal-body | GCST90002687 | 3.28 |
| 3447 | Disorders of breast | FING00000437 | 3.27 |
| 3448 | Cholesteryl esters to total lipids ratio in medium HDL | GCST90092895 | 3.27 |
| 3449 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T317 | ECGU000317 | 3.27 |
| 3450 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T94 | ECGU000094 | 3.27 |
| 3451 | Cholesteryl esters to total lipids ratio in large HDL | GCST90092847 | 3.26 |
| 3452 | ITGB1BP2/PTPN6 ratio | GCST90315218 | 3.26 |
| 3453 | Phospholipid levels in medium VLDL | GCST90092924 | 3.26 |
| 3454 | Omega-6 fatty acids to total fatty acids percentage | GCST90499203 | 3.26 |
| 3455 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393 | ECGU000393 | 3.26 |
| 3456 | Inpatient record format - UK HES In Patient (2015 format) | Summary Administration | UKBB00000364 | 3.26 |
| 3457 | T1 FreeSurfer BA lh V2 exvivo thickness | GCST90385529 | 3.26 |
| 3458 | ACTA2 levels | GCST90468208 | 3.26 |
| 3459 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T334 | ECGU000334 | 3.25 |
| 3460 | Concentration of medium LDL particles | GCST90498823 | 3.25 |
| 3461 | Haemoglobin concentration | Blood count | UKBB00000293 | 3.25 |
| 3462 | BAG6 levels | GCST90468418 | 3.25 |
| 3463 | SIGLEC9 levels | GCST90470637 | 3.25 |
| 3464 | CASP8/DDX58 ratio | GCST90313651 | 3.25 |
| 3465 | S100A13 levels | GCST90470514 | 3.24 |
| 3466 | BIRC2/CD40LG ratio | GCST90313517 | 3.24 |
| 3467 | T1 FreeSurfer DKT rh fusiform thickness | GCST90384322 | 3.24 |
| 3468 | ADH4/SCLY ratio | GCST90313195 | 3.24 |
| 3469 | High light scatter reticulocyte percentage (UKB data field 30290) | GCST90468077 | 3.24 |
| 3470 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392 | ECGU000392 | 3.23 |
| 3471 | NECTIN2/VSIR ratio | GCST90315533 | 3.23 |
| 3472 | Alzheimer's disease (MTAG) | GCST90449055 | 3.23 |
| 3473 | MILR1 levels | GCST90469907 | 3.23 |
| 3474 | ALCAM/NOTCH1 ratio | GCST90313241 | 3.23 |
| 3475 | Total bilirubin levels | GCST90278643 | 3.23 |
| 3476 | High light scatter reticulocyte count | Blood count | UKBB00000326 | 3.23 |
| 3477 | FETUB levels | GCST90469215 | 3.23 |
| 3478 | MVK levels | GCST90469967 | 3.23 |
| 3479 | NEFL levels | GCST90470024 | 3.23 |
| 3480 | Other chronic ischemic heart disease, unspecified (PheCode 411.8) | GCST90475938 | 3.23 |
| 3481 | aparc-a2009s lh area S-oc-middle+Lunatus | GCST90003353 | 3.22 |
| 3482 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T344 | ECGA000344 | 3.22 |
| 3483 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T362 | ECGU000362 | 3.21 |
| 3484 | CPB1/CTRB1 ratio | GCST90314208 | 3.21 |
| 3485 | CCN2/MGLL ratio | GCST90313714 | 3.21 |
| 3486 | Concentration of medium VLDL particles | GCST90499016 | 3.21 |
| 3487 | Left-hemisphere default mode network to putamen white-matter structural connectivity | GCST90302769 | 3.21 |
| 3488 | PLPBP levels | GCST90470260 | 3.20 |
| 3489 | PIK3IP1/TNFRSF1A ratio | GCST90315653 | 3.20 |
| 3490 | HBB levels | GCST90025969 | 3.20 |
| 3491 | CBLN4 levels | GCST90468554 | 3.20 |
| 3492 | ALDH1A1/PKLR ratio | GCST90313245 | 3.20 |
| 3493 | PRSS2 levels | GCST90470343 | 3.19 |
| 3494 | BACH1/SNX9 ratio | GCST90313447 | 3.19 |
| 3495 | Total cholesterol levels | GCST90278644 | 3.19 |
| 3496 | GRAP2/SNX9 ratio | GCST90314988 | 3.19 |
| 3497 | SIL1 levels | GCST90470638 | 3.18 |
| 3498 | Reaction time (standard GWA) | GCST90267296 | 3.18 |
| 3499 | Frequency of tenseness / restlessness in last 2 weeks | Mental health | UKBB00000267 | 3.18 |
| 3500 | DTI TBSS L3 Fornix | GCST90384529 | 3.18 |
| 3501 | Gout | GCST90399700 | 3.18 |
| 3502 | FGF5 levels | GCST90469226 | 3.17 |
| 3503 | LEPR/NRCAM ratio | GCST90315312 | 3.17 |
| 3504 | Acute pulmonary heart disease (PheCode 415.1) | GCST90475944 | 3.17 |
| 3505 | Alanine aminotransferase levels | GCST90278617 | 3.17 |
| 3506 | LGALS7 or LGALS7B levels | GCST90469763 | 3.17 |
| 3507 | DTI TBSS MD Cingulum cingulate gyrus R | GCST90384606 | 3.17 |
| 3508 | Seated height | Body size measures | UKBB00000763 | 3.17 |
| 3509 | IGSF9 levels | GCST90469541 | 3.16 |
| 3510 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417 | ECGU000417 | 3.16 |
| 3511 | BAG6/WASF1 ratio | GCST90313452 | 3.16 |
| 3512 | Mean corpuscular hemoglobin concentration | GCST004605 | 3.16 |
| 3513 | Phospholipids to total lipids ratio in medium HDL | GCST90092901 | 3.16 |
| 3514 | Total Lipids in LDL | GCST90498405 | 3.16 |
| 3515 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244 | ECGU000244 | 3.15 |
| 3516 | Biological Sibling: High cholesterol | GCST90476371 | 3.15 |
| 3517 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T154 | ECGA000154 | 3.15 |
| 3518 | X-18601 levels | GCST90243501 | 3.15 |
| 3519 | EGFLAM levels | GCST90421651 | 3.15 |
| 3520 | CASP8/PRDX6 ratio | GCST90313655 | 3.15 |
| 3521 | Gestational age at birth (maternal effect) | GCST90268419 | 3.15 |
| 3522 | CD69 levels | GCST90468643 | 3.15 |
| 3523 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T250 | ECGU000250 | 3.14 |
| 3524 | Mood swings | Mental health | UKBB00000482 | 3.14 |
| 3525 | HDL x low social support interaction (2df test) | GCST90570669 | 3.14 |
| 3526 | COL28A1 levels | GCST90468815 | 3.14 |
| 3527 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T146 | ECGA000146 | 3.14 |
| 3528 | Lactate levels | GCST90092882 | 3.14 |
| 3529 | ATXN10 levels | GCST90468401 | 3.14 |
| 3530 | AmygNuclei lh volume Accessory-Basal-nucleus | GCST90002650 | 3.14 |
| 3531 | Cholesterol in very small VLDL (UKB data field 23519) | GCST90269616 | 3.13 |
| 3532 | aparc-pial lh area lateralorbitofrontal | GCST90003152 | 3.13 |
| 3533 | Disorders of lipid metabolism (PheCode 272) | GCST90475715 | 3.13 |
| 3534 | CNTN2 levels | GCST90468804 | 3.13 |
| 3535 | Hair colour (natural, before greying) - Light brown | Sun exposure | UKBB00000298 | 3.13 |
| 3536 | RP2 levels | GCST90470493 | 3.13 |
| 3537 | Ankylosing spondylitis | FING00000089 | 3.12 |
| 3538 | Non-cancer illness code, self-reported - gout | Medical conditions | UKBB00000512 | 3.11 |
| 3539 | F7/F9 ratio | GCST90314743 | 3.11 |
| 3540 | SDC1 levels | GCST90470558 | 3.11 |
| 3541 | DTI TBSS MD Superior longitudinal fasciculus L | GCST90384613 | 3.11 |
| 3542 | GLO1 levels | GCST90469358 | 3.11 |
| 3543 | IDP dMRI TBSS ICVF Sagittal stratum L | GCST90004358 | 3.11 |
| 3544 | Hemoglobin concentration | GCST004615 | 3.11 |
| 3545 | Recent feelings of foreboding | Anxiety | UKBB00000738 | 3.11 |
| 3546 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488 | ECGA000488 | 3.10 |
| 3547 | GP1BA/SELP ratio | GCST90314958 | 3.10 |
| 3548 | Hemorrhoids | circulatory system | UKBB00000325 | 3.10 |
| 3549 | CCL15 levels | GCST90468567 | 3.10 |
| 3550 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 3.10 |
| 3551 | Principal component-derived dietary pattern 42 | GCST90133047 | 3.10 |
| 3552 | CKB levels | GCST90468759 | 3.10 |
| 3553 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite level | GCST90616403 | 3.09 |
| 3554 | Sarcoidosis | GCST90018698 | 3.09 |
| 3555 | YAP1 levels | GCST90471086 | 3.08 |
| 3556 | MTDH levels | GCST90469954 | 3.08 |
| 3557 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90500949 | 3.08 |
| 3558 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 3.08 |
| 3559 | Diacylglycerol_34:1_[M+H-H2O]1+ levels | GCST90060179 | 3.08 |
| 3560 | FAS levels | GCST90469192 | 3.08 |
| 3561 | RWDD1 levels | GCST90470510 | 3.08 |
| 3562 | DAB2 levels | GCST90468942 | 3.08 |
| 3563 | STK11 levels | GCST90470765 | 3.08 |
| 3564 | CDH6/NTRK2 ratio | GCST90313962 | 3.08 |
| 3565 | HDL cholesterol levels (UKB data field 30760) | GCST90468075 | 3.07 |
| 3566 | aparc-a2009s lh thickness S-postcentral | GCST90003669 | 3.07 |
| 3567 | High light scatter reticulocyte percentage | Blood count | UKBB00000327 | 3.07 |
| 3568 | Body mass index (BMI) | Impedance measures | UKBB00000104 | 3.07 |
| 3569 | Coronary heart disease | GCST000998 | 3.07 |
| 3570 | DFFA levels | GCST90468987 | 3.07 |
| 3571 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85 | ECGU000085 | 3.07 |
| 3572 | ACVRL1/TNFRSF10B ratio | GCST90313158 | 3.06 |
| 3573 | CCL25/PRSS27 ratio | GCST90313694 | 3.06 |
| 3574 | HMOX1 levels | GCST90469465 | 3.06 |
| 3575 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T138 | ECGA000138 | 3.06 |
| 3576 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T353 | ECGA000353 | 3.06 |
| 3577 | Phospholipids to Total Lipids in IDL percentage | GCST90497642 | 3.06 |
| 3578 | CD46 levels | GCST90468634 | 3.06 |
| 3579 | ALKBH3 levels | GCST90619095 | 3.05 |
| 3580 | Omega-6 fatty acids to total fatty acids percentage | GCST90499210 | 3.05 |
| 3581 | IDP dMRI ProbtrackX ICVF slf l | GCST90004396 | 3.05 |
| 3582 | COMP/THBS4 ratio | GCST90314193 | 3.05 |
| 3583 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257 | ECGA000257 | 3.05 |
| 3584 | Phospholipids in LDL (UKB data field 23413) | GCST90269510 | 3.05 |
| 3585 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T162 | ECGA000162 | 3.04 |
| 3586 | Alzheimer's disease (MTAG) | GCST90449062 | 3.04 |
| 3587 | Hippocampal subfield left CA4 volume (head) | GCST90267943 | 3.04 |
| 3588 | Job involves heavy manual or physical work | Employment | UKBB00000383 | 3.04 |
| 3589 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T47 | ECGA000047 | 3.04 |
| 3590 | SLPI levels | GCST90426030 | 3.04 |
| 3591 | ALB levels | UKBB00000019 | 3.04 |
| 3592 | Right ventricular end diastolic volume | GCST90134588 | 3.03 |
| 3593 | Cholesteryl Esters to Total Lipids in Small LDL percentage | GCST90499602 | 3.03 |
| 3594 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T188 | ECGU000188 | 3.03 |
| 3595 | Phospholipids in IDL (UKB data field 23525) | GCST90269622 | 3.03 |
| 3596 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T143 | ECGA000143 | 3.03 |
| 3597 | Alzheimer's disease or family history of Alzheimer's disease | GCST90012877 | 3.03 |
| 3598 | Heart failure and coronary heart disease | FING00000604 | 3.03 |
| 3599 | F-fruit liking (derived food-liking factor) | GCST90094767 | 3.02 |
| 3600 | VLDL cholesterol levels | GCST90500196 | 3.02 |
| 3601 | Total fatty acid levels | GCST90502220 | 3.01 |
| 3602 | Noninfectious gastroenteritis | digestive | UKBB00000526 | 3.01 |
| 3603 | IDP dMRI TBSS MD Uncinate fasciculus L | GCST90004072 | 3.01 |
| 3604 | Phosphatidylcholine-2O_32:0_[M+H]1+ levels | GCST90060244 | 3.01 |
| 3605 | MED18/SMAD1 ratio | GCST90315413 | 3.01 |
| 3606 | aparc-Desikan lh area lateraloccipital | GCST90003083 | 3.01 |
| 3607 | Other serious medical condition/disability diagnosed by doctor | Medical conditions | UKBB00000619 | 3.01 |
| 3608 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T326 | ECGA000326 | 3.00 |
| 3609 | wg rh intensity-contrast insula | GCST90003861 | 3.00 |
| 3610 | Whole body fat free mass (UKB data field 23101) | GCST90428120 | 3.00 |
| 3611 | ACVRL1/SCARB2 ratio | GCST90313157 | 3.00 |
| 3612 | PROK1 levels | GCST90470336 | 3.00 |
| 3613 | Ischemic Heart Disease | circulatory system | UKBB00000381 | 2.99 |
| 3614 | EIF4EBP1 levels | GCST90469095 | 2.99 |
| 3615 | Total fatty acid levels | GCST90500061 | 2.99 |
| 3616 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T129 | ECGU000129 | 2.99 |
| 3617 | Pelvic width | GCST90448911 | 2.98 |
| 3618 | Testosterone levels | GCST90483486 | 2.98 |
| 3619 | FLI1 levels | GCST90469247 | 2.98 |
| 3620 | PDGFA/SERPINE1 ratio | GCST90315618 | 2.98 |
| 3621 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475350 | 2.98 |
| 3622 | LDLRAP1 levels | GCST90469749 | 2.97 |
| 3623 | RET levels | GCST90470458 | 2.97 |
| 3624 | SPARCL1 levels | GCST90242870 | 2.97 |
| 3625 | acne vulgaris | GCST90245818 | 2.97 |
| 3626 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487 | ECGA000487 | 2.97 |
| 3627 | Platelet count | GCST90002358 | 2.96 |
| 3628 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5 | ECGA000005 | 2.96 |
| 3629 | F8 levels | GCST90240725 | 2.96 |
| 3630 | PTPRZ1 levels | GCST90470388 | 2.96 |
| 3631 | DTI TBSS MD Anterior limb of internal capsule L | GCST90384589 | 2.95 |
| 3632 | Intracerebral hemorrhage | GCST90018650 | 2.95 |
| 3633 | DTI TBSS L3 External capsule L | GCST90384557 | 2.95 |
| 3634 | 1-ribosyl-imidazoleacetate levels | GCST90199815 | 2.95 |
| 3635 | Sphingomyelin_39:1_[M+H]1+ levels | GCST90060328 | 2.95 |
| 3636 | Triacylglycerol_50:4_[M+NH4]1+ levels | GCST90060466 | 2.95 |
| 3637 | Left-hemisphere control network to thalamus white-matter structural connectivity | GCST90302752 | 2.95 |
| 3638 | DTI autoptx L1 ilf l tract | GCST90385153 | 2.94 |
| 3639 | ARHGEF12/DECR1 ratio | GCST90313349 | 2.94 |
| 3640 | Right-hemisphere control network to thalamus white-matter structural connectivity | GCST90302836 | 2.94 |
| 3641 | Alzheimer's disease (MTAG) | GCST90449058 | 2.94 |
| 3642 | IDP dMRI ProbtrackX FA unc r | GCST90003951 | 2.94 |
| 3643 | Total lipids in lipoprotein particles (UKB data field 23423) | GCST90269520 | 2.94 |
| 3644 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T206 | ECGU000206 | 2.94 |
| 3645 | Total lipids in small LDL | GCST90499652 | 2.94 |
| 3646 | Crisps liking | GCST90094747 | 2.94 |
| 3647 | CD300C/CLEC14A ratio | GCST90313786 | 2.93 |
| 3648 | EPO levels | GCST90469136 | 2.93 |
| 3649 | Right-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302840 | 2.93 |
| 3650 | aseg lh volume CerebralWhiteMatter | GCST90002615 | 2.93 |
| 3651 | aseg rh volume Lateral-Ventricle | GCST90002633 | 2.93 |
| 3652 | DTI autoptx L3 ifo r tract | GCST90385206 | 2.93 |
| 3653 | TGFBR2 levels | GCST90470847 | 2.93 |
| 3654 | Stool frequency | GCST90002250 | 2.93 |
| 3655 | Metabolic syndrome | GCST90444487 | 2.93 |
| 3656 | BPIFB1/GLRX ratio | GCST90313530 | 2.92 |
| 3657 | DGKA levels | GCST90468989 | 2.92 |
| 3658 | Small cell lung carcinoma | GCST004746 | 2.92 |
| 3659 | Hyperlipidemia (PheCode 272.1) | GCST90475718 | 2.92 |
| 3660 | Free cholesterol levels in VLDL | GCST90092998 | 2.92 |
| 3661 | HSPG2/VASN ratio | GCST90315094 | 2.92 |
| 3662 | Right ventricular end systolic volume | GCST90134589 | 2.92 |
| 3663 | FLT4 levels | GCST90469252 | 2.91 |
| 3664 | F-seafood liking (derived food-liking factor) | GCST90094836 | 2.91 |
| 3665 | Radiculopathy | FING00001238 | 2.91 |
| 3666 | AKT1S1 levels | GCST90468276 | 2.91 |
| 3667 | HGF/PDGFB ratio | GCST90315058 | 2.91 |
| 3668 | Uterine leiomyomata | GCST90239856 | 2.91 |
| 3669 | Total Lipids in Medium LDL | GCST90498806 | 2.91 |
| 3670 | Urinary ethanolamine to urinary creatinine ratio | GCST90451717 | 2.91 |
| 3671 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419 | ECGU000419 | 2.91 |
| 3672 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T120 | ECGA000120 | 2.91 |
| 3673 | Number of diet questionnaires completed | Diet questionnaire performance | UKBB00000536 | 2.90 |
| 3674 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T153 | ECGA000153 | 2.90 |
| 3675 | Principal component-derived dietary pattern 1 | GCST90133006 | 2.90 |
| 3676 | Cancer of liver and intrahepatic bile duct (PheCode 155) | GCST90475568 | 2.90 |
| 3677 | Peripheral vascular disease | GCST90475996 | 2.90 |
| 3678 | Anterior thigh muscle fat infiltration percentage | GCST90267351 | 2.90 |
| 3679 | TPI1 levels | GCST90088659 | 2.90 |
| 3680 | ThalamNuclei rh volume VAmc | GCST90002747 | 2.90 |
| 3681 | Retinal thickness (functional principal component 5) | GCST90455725 | 2.90 |
| 3682 | MGLL levels | GCST90469901 | 2.89 |
| 3683 | GFRA1/TNFRSF1A ratio | GCST90314924 | 2.89 |
| 3684 | Nonspecific chest pain | circulatory system | UKBB00000527 | 2.89 |
| 3685 | Pneumoconiosis due to other inorganic dusts | FING00001173 | 2.89 |
| 3686 | AKR1B1 levels | GCST90468273 | 2.89 |
| 3687 | aparc-a2009s lh volume S-subparietal | GCST90002995 | 2.89 |
| 3688 | SMOC1 levels | GCST90470682 | 2.89 |
| 3689 | NELL2 levels | GCST90470027 | 2.89 |
| 3690 | Osteoarthritis | GCST90468144 | 2.89 |
| 3691 | MANSC4 levels | GCST90469848 | 2.89 |
| 3692 | KIRREL2/PLA2G1B ratio | GCST90315251 | 2.89 |
| 3693 | HEXIM1/IKBKG ratio | GCST90315045 | 2.89 |
| 3694 | Polyarthrosis | FING00001181 | 2.88 |
| 3695 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T155 | ECGA000155 | 2.88 |
| 3696 | Inflammatory markers and poor diet (confirmatory factor analysis Factor 30) | GCST90309364 | 2.88 |
| 3697 | Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621) | GCST90269718 | 2.88 |
| 3698 | Cholesteryl esters in LDL (UKB data field 23417) | GCST90269514 | 2.87 |
| 3699 | FOXJ3 levels | GCST90469264 | 2.87 |
| 3700 | Free Cholesterol in VLDL | GCST90500221 | 2.87 |
| 3701 | Pulmonary embolism and infarction, acute (PheCode 415.11) | GCST90475946 | 2.87 |
| 3702 | OMD/SPP1 ratio | GCST90315586 | 2.87 |
| 3703 | CHAD levels | GCST90468737 | 2.87 |
| 3704 | IDP T1 FAST ROIs brain stem | GCST90002561 | 2.87 |
| 3705 | CST3/RETN ratio | GCST90314297 | 2.87 |
| 3706 | PDGFB/SDC4 ratio | GCST90315626 | 2.87 |
| 3707 | CELA3A/CTRC ratio | GCST90314012 | 2.87 |
| 3708 | Right-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302834 | 2.87 |
| 3709 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394 | ECGU000394 | 2.86 |
| 3710 | Free cholesterol in IDL (UKB data field 23528) | GCST90269625 | 2.86 |
| 3711 | Reticulocyte count | Blood count | UKBB00000752 | 2.86 |
| 3712 | Urine taurocholenate sulfate* levels in chronic kidney disease | GCST90266041 | 2.86 |
| 3713 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T149 | ECGA000149 | 2.86 |
| 3714 | 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels | GCST90200065 | 2.86 |
| 3715 | Type of accommodation lived in - A flat, maisonette or apartment | Household | UKBB00000868 | 2.85 |
| 3716 | Occupational creativity | GCST90308774 | 2.85 |
| 3717 | Total lipids in medium VLDL | GCST90499004 | 2.85 |
| 3718 | Colorectal cancer, excluding all cancers (controls excluding all cancers) | FING00000317 | 2.85 |
| 3719 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46 | ECGA000046 | 2.85 |
| 3720 | UBA9475 sp002161235 abundance in stool | GCST90032635 | 2.85 |
| 3721 | GALNT7 levels | GCST90469299 | 2.85 |
| 3722 | HEPH levels | GCST90469446 | 2.85 |
| 3723 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T385 | ECGU000385 | 2.85 |
| 3724 | Depression | FING00000398 | 2.84 |
| 3725 | ACRBP levels | GCST90468205 | 2.84 |
| 3726 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76 | ECGA000076 | 2.84 |
| 3727 | High light scatter reticulocyte count (UKB data field 30300) | GCST90468076 | 2.83 |
| 3728 | DPEP2 levels | GCST90469031 | 2.83 |
| 3729 | Cardiorespiratory fitness slope | GCST90093320 | 2.83 |
| 3730 | MED18/SH2B3 ratio | GCST90315412 | 2.83 |
| 3731 | DTI TBSS FA Anterior corona radiata R | GCST90384402 | 2.83 |
| 3732 | NECTIN2/SDC1 ratio | GCST90315529 | 2.83 |
| 3733 | Cholesteryl ester levels in LDL | GCST90092884 | 2.82 |
| 3734 | Ischemic heart disease (PheCode 411) | GCST90475929 | 2.82 |
| 3735 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498000 | 2.82 |
| 3736 | Propionylcarnitine levels | GCST90243593 | 2.82 |
| 3737 | Reticulocyte count (UKB data field 30250) | GCST90468100 | 2.82 |
| 3738 | IDP dMRI TBSS L3 Body of corpus callosum | GCST90004174 | 2.81 |
| 3739 | TMPRSS5 levels | GCST90470893 | 2.81 |
| 3740 | Degree of unsaturation | GCST90502233 | 2.81 |
| 3741 | CLEC1B/DAB2 ratio | GCST90314086 | 2.81 |
| 3742 | Congenital iodine-deficiency syndrome/hypothyroidism | FING00000328 | 2.81 |
| 3743 | Childhood maltreatment | GCST90551832 | 2.81 |
| 3744 | Neutrophill count (UKB data field 30140) | GCST90468092 | 2.81 |
| 3745 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T380 | ECGU000380 | 2.81 |
| 3746 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502077 | 2.81 |
| 3747 | Multi-trait sex score | GCST90270116 | 2.80 |
| 3748 | Urticaria | GCST90018716 | 2.80 |
| 3749 | Right ventricular stroke volume | GCST90134590 | 2.80 |
| 3750 | HSPB1/QDPR ratio | GCST90315089 | 2.80 |
| 3751 | AGXT/GRPEL1 ratio | GCST90313205 | 2.80 |
| 3752 | Calcium | Blood biochemistry | UKBB00000114 | 2.80 |
| 3753 | CLSTN2 levels | GCST90468789 | 2.79 |
| 3754 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T152 | ECGA000152 | 2.79 |
| 3755 | Cardiomyopathy | GCST90399705 | 2.79 |
| 3756 | NRGN levels | GCST90470083 | 2.78 |
| 3757 | DTI TBSS FA Retrolenticular part of internal capsule R | GCST90384400 | 2.78 |
| 3758 | Cholesteryl Esters in LDL | GCST90498363 | 2.78 |
| 3759 | CANT1/HSPB1 ratio | GCST90313617 | 2.78 |
| 3760 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392 | ECGA000392 | 2.78 |
| 3761 | total cholesterol (maximum, inv-norm transformed) | GCST90476420 | 2.78 |
| 3762 | S100A4 levels | GCST90470518 | 2.78 |
| 3763 | B4GALT1/SMOC2 ratio | GCST90313433 | 2.78 |
| 3764 | DTI TBSS MD Posterior thalamic radiation L | GCST90384601 | 2.78 |
| 3765 | Subarachnoid hemorrhage | GCST90018703 | 2.77 |
| 3766 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T309 | ECGU000309 | 2.77 |
| 3767 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T111 | ECGU000111 | 2.77 |
| 3768 | Cholesteryl esters in very small VLDL (UKB data field 23520) | GCST90269617 | 2.77 |
| 3769 | Concentration of LDL particles | GCST90498413 | 2.77 |
| 3770 | Pelvic height | GCST90448912 | 2.77 |
| 3771 | Calcium levels (UKB data field 30680) | GCST90468065 | 2.77 |
| 3772 | Carboplatin drug response (IC50) | GCST90011783 | 2.77 |
| 3773 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T325 | ECGA000325 | 2.76 |
| 3774 | Thyroid stimulating hormone levels | GCST90319321 | 2.76 |
| 3775 | MANSC1/PODXL2 ratio | GCST90315371 | 2.76 |
| 3776 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52) | GCST90320871 | 2.76 |
| 3777 | ANXA3 levels | GCST90468318 | 2.76 |
| 3778 | Hair colour (natural, before greying): Light brown (UKB data field 1747_3) | GCST90041838 | 2.76 |
| 3779 | Right ventricular peak atrial filling rate | GCST90268119 | 2.75 |
| 3780 | aparc-a2009s rh thickness Pole-occipital | GCST90003718 | 2.75 |
| 3781 | CCN5 levels | GCST90468591 | 2.75 |
| 3782 | Kidney transplant status | FING00000710 | 2.75 |
| 3783 | aparc-Desikan lh volume caudalmiddlefrontal | GCST90002771 | 2.75 |
| 3784 | Phospholipids to Total Lipids in Medium VLDL percentage | GCST90499043 | 2.75 |
| 3785 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T308 | ECGU000308 | 2.75 |
| 3786 | CPB1/REG1A ratio | GCST90314212 | 2.75 |
| 3787 | Total lipid levels in LDL | GCST90092886 | 2.74 |
| 3788 | DTD1 levels | GCST90469045 | 2.74 |
| 3789 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T228 | ECGA000228 | 2.74 |
| 3790 | Free Cholesterol to Total Lipids in Medium LDL percentage | GCST90498783 | 2.74 |
| 3791 | FOLH1 levels | GCST90427192 | 2.74 |
| 3792 | Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.) | GCST90027638 | 2.74 |
| 3793 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T30 | ECGA000030 | 2.74 |
| 3794 | Free cholesterol to total lipids ratio in IDL | GCST90092836 | 2.74 |
| 3795 | Disorders of other endocrine glands | FING00000450 | 2.73 |
| 3796 | Water consumption (glasses per day) (UKB data field 1528) | GCST90132985 | 2.73 |
| 3797 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320629 | 2.73 |
| 3798 | Total Lipids in Medium LDL | GCST90498800 | 2.73 |
| 3799 | HPGDS levels | GCST90469472 | 2.73 |
| 3800 | DTI autoptx L2 slf r tract | GCST90385188 | 2.73 |
| 3801 | Coronary artery disease (confirmatory factor analysis Factor 16) | GCST90309350 | 2.72 |
| 3802 | DBI/TMSB10 ratio | GCST90314414 | 2.72 |
| 3803 | Thyroxine levels | GCST90200293 | 2.72 |
| 3804 | Total lipids in large LDL (UKB data field 23531) | GCST90269628 | 2.72 |
| 3805 | F-strong vegetable liking (derived food-liking factor) | GCST90094852 | 2.72 |
| 3806 | DPP4/ITGB1 ratio | GCST90314540 | 2.72 |
| 3807 | IDP T1 FIRST right pallidum volume | GCST90002443 | 2.72 |
| 3808 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T73 | ECGU000073 | 2.71 |
| 3809 | Mean corpuscular hemoglobin | GCST90018744 | 2.71 |
| 3810 | Omega-6 fatty acid levels | GCST90502502 | 2.71 |
| 3811 | Cholesteryl Esters in VLDL | GCST90500211 | 2.71 |
| 3812 | Duration of walks | Physical activity | UKBB00000200 | 2.71 |
| 3813 | Right ventricular stroke volume (MTAG) | GCST90134594 | 2.71 |
| 3814 | Vitamin D levels | GCST005367 | 2.71 |
| 3815 | EPHA2 levels | GCST90469130 | 2.71 |
| 3816 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T369 | ECGU000369 | 2.71 |
| 3817 | Facial pigmentation measurement (UV light) | GCST90002283 | 2.71 |
| 3818 | Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731) | GCST90476246 | 2.70 |
| 3819 | Use of disulfiram, acamprosate or naltrexone | FING00001410 | 2.70 |
| 3820 | IDP dMRI TBSS MO Superior corona radiata R | GCST90003976 | 2.70 |
| 3821 | FUT3_FUT5/LILRA2 ratio | GCST90314889 | 2.70 |
| 3822 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T420 | ECGU000420 | 2.70 |
| 3823 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T327 | ECGA000327 | 2.70 |
| 3824 | Subpubic angle | GCST90448908 | 2.70 |
| 3825 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T151 | ECGA000151 | 2.70 |
| 3826 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T131 | ECGA000131 | 2.70 |
| 3827 | X-24947 levels | GCST90200651 | 2.69 |
| 3828 | NECTIN2 levels | GCST90470020 | 2.69 |
| 3829 | aparc-Desikan lh volume lateraloccipital | GCST90002778 | 2.69 |
| 3830 | CCL11 levels | GCST90274764 | 2.69 |
| 3831 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87) | GCST90320906 | 2.69 |
| 3832 | Hemoglobin | GCST90002384 | 2.69 |
| 3833 | CLEC1B/TXNDC5 ratio | GCST90314105 | 2.69 |
| 3834 | CD274/EFNA4 ratio | GCST90313768 | 2.69 |
| 3835 | Treatment speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000835 | 2.69 |
| 3836 | VNN1 levels | GCST90471043 | 2.69 |
| 3837 | Neutrophill count | Blood count | UKBB00000497 | 2.69 |
| 3838 | VTA1 levels | GCST90471058 | 2.69 |
| 3839 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499690 | 2.68 |
| 3840 | Cholesteryl Esters to Total Lipids in Small LDL percentage | GCST90499595 | 2.68 |
| 3841 | NFU1 levels | GCST90470040 | 2.68 |
| 3842 | Depressive episode | Mood [affective] disorders | UKBB00000166 | 2.68 |
| 3843 | DTI autoptx L2 atr r tract | GCST90385169 | 2.68 |
| 3844 | SERPINB1 levels | GCST90470589 | 2.68 |
| 3845 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T350 | ECGA000350 | 2.67 |
| 3846 | C20:4 Lysophosphatidylcholine levels in chronic kidney disease | GCST90257570 | 2.67 |
| 3847 | Feeling miserable | GCST006943 | 2.67 |
| 3848 | LACTB2 levels | GCST90469726 | 2.67 |
| 3849 | Hip circumference | Body size measures | UKBB00000328 | 2.67 |
| 3850 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475458 | 2.67 |
| 3851 | Polyunsaturated fatty acid levels | GCST90092939 | 2.67 |
| 3852 | CTF1 levels | GCST90468901 | 2.67 |
| 3853 | Duration of heavy DIY | Physical activity | UKBB00000195 | 2.67 |
| 3854 | DTI TBSS L3 Retrolenticular part of internal capsule R | GCST90384544 | 2.67 |
| 3855 | Linoleic acid levels (UKB data field 23449) | GCST90269546 | 2.66 |
| 3856 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3 | ECGA000003 | 2.66 |
| 3857 | Polyunsaturated fatty acids levels (UKB data field 23446) | GCST90269543 | 2.66 |
| 3858 | IDP dMRI ProbtrackX FA str l | GCST90003948 | 2.66 |
| 3859 | NCAM2 levels | GCST90470004 | 2.65 |
| 3860 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T358 | ECGU000358 | 2.65 |
| 3861 | IL18R1 levels | GCST90469565 | 2.65 |
| 3862 | DTI TBSS L3 Anterior corona radiata R | GCST90384546 | 2.65 |
| 3863 | VAMP8 levels | GCST90471025 | 2.65 |
| 3864 | IDP dMRI ProbtrackX ISOVF cgc l | GCST90004529 | 2.64 |
| 3865 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T300 | ECGU000300 | 2.64 |
| 3866 | Free Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498988 | 2.64 |
| 3867 | High cholesterol | GCST90475205 | 2.64 |
| 3868 | EFNA1/PIK3IP1 ratio | GCST90314598 | 2.64 |
| 3869 | LDL (standard GWA) | GCST90267272 | 2.64 |
| 3870 | GAS6/NOTCH1 ratio | GCST90314918 | 2.64 |
| 3871 | AXIN1/MAVS ratio | GCST90313414 | 2.64 |
| 3872 | Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels | GCST90060284 | 2.64 |
| 3873 | MAD1L1/POLR2F ratio | GCST90315354 | 2.63 |
| 3874 | ENO3 levels | GCST90469111 | 2.63 |
| 3875 | IDP dMRI ProbtrackX L1 fmi | GCST90004257 | 2.63 |
| 3876 | NT5C levels | GCST90470092 | 2.63 |
| 3877 | Spontaneous coronary artery dissection | GCST90245878 | 2.63 |
| 3878 | FKBP4/SIRT2 ratio | GCST90314841 | 2.63 |
| 3879 | ITGA5 levels | GCST90469635 | 2.63 |
| 3880 | Free Cholesterol in LDL | GCST90498386 | 2.63 |
| 3881 | CSF1 levels | GCST90468881 | 2.63 |
| 3882 | TANK levels | GCST90470803 | 2.62 |
| 3883 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T344 | ECGU000344 | 2.62 |
| 3884 | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | GCST90132992 | 2.62 |
| 3885 | Cerebrospinal fluid sulfate* levels | GCST90318056 | 2.62 |
| 3886 | CD163/FOLR2 ratio | GCST90313734 | 2.62 |
| 3887 | IDO1 levels | GCST90241490 | 2.61 |
| 3888 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T81 | ECGA000081 | 2.61 |
| 3889 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498714 | 2.61 |
| 3890 | Irritable bowel syndrome | FING00000702 | 2.61 |
| 3891 | SEZ6 levels | GCST90470608 | 2.61 |
| 3892 | DTI TBSS MD External capsule L | GCST90384605 | 2.61 |
| 3893 | Hallux valgus (Bunion) | musculoskeletal | UKBB00000299 | 2.60 |
| 3894 | X-13671 levels | GCST90243829 | 2.60 |
| 3895 | GLA levels | GCST90469354 | 2.60 |
| 3896 | Monoclonal gammopathy of undetermined significance | GCST90624745 | 2.60 |
| 3897 | ENPP2 levels | GCST90469115 | 2.60 |
| 3898 | TMSB10 levels | GCST90470894 | 2.60 |
| 3899 | Administrative and legal statuses - NHS patient: not formally detained | Summary Administration | UKBB00000012 | 2.60 |
| 3900 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T156 | ECGA000156 | 2.59 |
| 3901 | HLA-DQA2 levels | GCST90427049 | 2.59 |
| 3902 | APRT levels | GCST90468345 | 2.59 |
| 3903 | Total lipids in LDL (UKB data field 23425) | GCST90269522 | 2.59 |
| 3904 | CLEC1B/LBR ratio | GCST90314095 | 2.59 |
| 3905 | Right-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302831 | 2.59 |
| 3906 | Pyruvate levels | GCST90092942 | 2.59 |
| 3907 | Neutrophil count | GCST004629 | 2.59 |
| 3908 | SERPINB6 levels | GCST90470591 | 2.58 |
| 3909 | CXCL13 levels | GCST90468926 | 2.58 |
| 3910 | Fibromuscular dysplasia | GCST90026612 | 2.58 |
| 3911 | SPTLC1 levels | GCST90427130 | 2.58 |
| 3912 | triglyceride (mean, inv-norm transformed) | GCST90476433 | 2.58 |
| 3913 | ADAMTS4 levels | GCST90468226 | 2.58 |
| 3914 | Cholesteryl Esters in Medium LDL | GCST90498739 | 2.58 |
| 3915 | BLVRB/CA1 ratio | GCST90313521 | 2.58 |
| 3916 | NUCB2/TRIAP1 ratio | GCST90315577 | 2.57 |
| 3917 | KLK8 levels | GCST90469707 | 2.57 |
| 3918 | Arterial stiffness index | GCST008403 | 2.57 |
| 3919 | Right ventricular end diastolic volume | GCST90268116 | 2.57 |
| 3920 | Diacylglycerol_33:1_[M+H-H2O]1+ levels | GCST90060173 | 2.57 |
| 3921 | AGRN/BTN2A1 ratio | GCST90313199 | 2.56 |
| 3922 | Red blood cell count | GCST004601 | 2.56 |
| 3923 | Left-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302767 | 2.56 |
| 3924 | PSRC1 levels | GCST90470365 | 2.56 |
| 3925 | Arm fat percentage (left) | Impedance measures | UKBB00000045 | 2.56 |
| 3926 | Parental longevity (father's attained age) | GCST006701 | 2.56 |
| 3927 | T1 FreeSurfer aseg rhCerebralWhiteMatterVol | GCST90384186 | 2.56 |
| 3928 | CCN1/DNAJB1 ratio | GCST90313709 | 2.56 |
| 3929 | Monounsaturated fatty acid levels | GCST90502038 | 2.56 |
| 3930 | Deep vein thrombosis [DVT] (PheCode 452.2) | GCST90476010 | 2.55 |
| 3931 | TOP1 levels | GCST90470933 | 2.55 |
| 3932 | ADAM9 levels | GCST90468221 | 2.55 |
| 3933 | DTI TBSS L2 Uncinate fasciculus L | GCST90384521 | 2.55 |
| 3934 | Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels | GCST90060243 | 2.55 |
| 3935 | aseg global volume-ratio BrainSegVol-to-eTIV | GCST90002612 | 2.55 |
| 3936 | Hypercholesterolemia | endocrine/metabolic | UKBB00000332 | 2.55 |
| 3937 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55 | ECGA000055 | 2.55 |
| 3938 | Glucose levels | GCST90092819 | 2.55 |
| 3939 | TRIM58 levels | GCST90470969 | 2.54 |
| 3940 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T329 | ECGU000329 | 2.54 |
| 3941 | ANXA3/HCLS1 ratio | GCST90313282 | 2.54 |
| 3942 | PODXL2/SEZ6L ratio | GCST90315702 | 2.54 |
| 3943 | Ischaemic heart disease, wide definition | FING00000703 | 2.54 |
| 3944 | Any dementia (more control exclusions) | FING00000099 | 2.54 |
| 3945 | CD200/CNTNAP2 ratio | GCST90313747 | 2.54 |
| 3946 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | GCST90004070 | 2.54 |
| 3947 | total cholesterol (maximum, inv-norm transformed) | GCST90476418 | 2.54 |
| 3948 | CXCL11/ITGB1BP2 ratio | GCST90314335 | 2.54 |
| 3949 | CDKN1A levels | GCST90468684 | 2.54 |
| 3950 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498723 | 2.54 |
| 3951 | PDLIM7/SRC ratio | GCST90315639 | 2.53 |
| 3952 | Cholesteryl esters in large LDL (UKB data field 23534) | GCST90269631 | 2.53 |
| 3953 | IDP dMRI TBSS FA Anterior corona radiata L | GCST90003900 | 2.53 |
| 3954 | IDP dMRI ProbtrackX ICVF mcp | GCST90004391 | 2.53 |
| 3955 | HPCAL1/NUDC ratio | GCST90315074 | 2.53 |
| 3956 | Cholesterol in IDL (UKB data field 23526) | GCST90269623 | 2.53 |
| 3957 | Ascending aorta strain | GCST90267388 | 2.53 |
| 3958 | LRIG1 levels | GCST90469794 | 2.53 |
| 3959 | Operative procedures - Haemorrhoidectomy | Summary Operations | UKBB00000580 | 2.53 |
| 3960 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 2.53 |
| 3961 | IGF2R/RNASET2 ratio | GCST90315132 | 2.53 |
| 3962 | RECK levels | GCST90470445 | 2.53 |
| 3963 | GP2/SELE ratio | GCST90314962 | 2.52 |
| 3964 | CRELD2/F2R ratio | GCST90314254 | 2.52 |
| 3965 | Adenomyosis (Endometriosis of uterus) | FING00000042 | 2.52 |
| 3966 | Major dietary changes in the last 5 years - Yes, because of illness | Diet | UKBB00000422 | 2.52 |
| 3967 | BA-exvivo rh thickness BA2 | GCST90003528 | 2.52 |
| 3968 | APRT/NSFL1C ratio | GCST90313337 | 2.52 |
| 3969 | wg lh intensity-contrast lateralorbitofrontal | GCST90003803 | 2.52 |
| 3970 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | GCST90004369 | 2.52 |
| 3971 | Generalized epilepsy | FING00000567 | 2.52 |
| 3972 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T281 | ECGA000281 | 2.52 |
| 3973 | X-17676 levels | GCST90200548 | 2.52 |
| 3974 | ZBTB16 levels | GCST90471095 | 2.52 |
| 3975 | TNFRSF21 levels | GCST90470912 | 2.51 |
| 3976 | FKBP4 levels | GCST90469243 | 2.51 |
| 3977 | aparc-pial lh area caudalmiddlefrontal | GCST90003144 | 2.51 |
| 3978 | Linoleic acid levels | GCST90092880 | 2.51 |
| 3979 | DBH levels | GCST90468948 | 2.51 |
| 3980 | aparc-DKTatlas rh thickness transversetemporal | GCST90003601 | 2.50 |
| 3981 | IDP dMRI ProbtrackX L3 str l | GCST90004323 | 2.50 |
| 3982 | Spread type - Butter/spreadable butter | Diet | UKBB00000793 | 2.50 |
| 3983 | CCL5/TFPI ratio | GCST90313708 | 2.50 |
| 3984 | NRSN1 levels | GCST90242062 | 2.50 |
| 3985 | Glutamine levels | GCST90497282 | 2.50 |
| 3986 | NCR3 levels | GCST90088179 | 2.49 |
| 3987 | CDA levels | GCST90468660 | 2.49 |
| 3988 | Stress incontinence, female | genitourinary | UKBB00000797 | 2.49 |
| 3989 | CEACAM8/PGLYRP1 ratio | GCST90314003 | 2.49 |
| 3990 | Cholesterol in large LDL (UKB data field 23533) | GCST90269630 | 2.49 |
| 3991 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499569 | 2.48 |
| 3992 | X-21364 levels | GCST90200566 | 2.48 |
| 3993 | Pulmonary heart disease (PheCode 415) | GCST90475942 | 2.48 |
| 3994 | CDHR1 levels | GCST90468678 | 2.48 |
| 3995 | IDP dMRI ProbtrackX MD unc r | GCST90004245 | 2.48 |
| 3996 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T388 | ECGU000388 | 2.48 |
| 3997 | DTI TBSS MD Fornix | GCST90384577 | 2.48 |
| 3998 | APOB levels | GCST90497137 | 2.48 |
| 3999 | Cholesteryl Esters to Total Lipids in Medium LDL percentage | GCST90498758 | 2.48 |
| 4000 | ALCAM/IL1RL2 ratio | GCST90313238 | 2.47 |